Ragini Kudchadkar on Treating Patients with Basal Cell Carcinoma
Ragini Kudchadkar, MD, explains what nurses should keep in mind when treating patients with basal cell carcinoma.
Ragini Kudchadkar, MD, from Winship Cancer Institute, explains what nurses should keep in mind when treating patients with basal cell carcinoma.
Often, patients with basal cell carcinoma will have had prior difficulties with access to care. As such, nurses should be ready to support the patients during this process, with medications, insurance, payments, and paperwork. Side effects from hedgehog inhibitors can be difficult as well: taste loss, weight loss, hair loss and muscle cramping. Nurses should help patients with compliance and encourage them to keep up with supplements to maintain a healthy weight.
Cemiplimab as Adjuvant Therapy Improves DFS in High-Risk Cutaneous Squamous Cell Carcinoma
January 20th 2025Adjuvant cemiplimab demonstrated a statistically significant improvement in DFS compared to placebo in post-surgical patients with high-risk CSCC, impacting post-operative care considerations.
